BioSpace News Archive

Mitsubishi Tanabe Pharma Canada is deeply committed to bringing RADICAVA® to people living with ALS, and as part of our commitment we are pleased to announce that RADICAVA will be available in Canada beginning on November 5, 2019.

The article is titled “In silico Molecular Target Validation Demonstrates Transforming Growth Factor Beta 2 is Strongly Expressed in Pediatric Diffuse Intrinsic Pontine Glioma and Glioblastoma Multiforme”

Intent is to collaborate on projects to advance the state of clinical research diagnostic technologies with a focus on women’s health.

Walgreens Boots Alliance, Inc. announced that its board of directors has declared a quarterly dividend of 45.75 cents per share, unchanged from the previous quarter and an increase of 4 percent from the year-ago quarter. The dividend is payable December 12, 2019, to stockholders of record as of November 18, 2019..

United Health Products, Inc. announced that four surgeons who participated in the recently completed human clinical trial for HemoStyp are preparing and submitting a journal article entitled Efficacy and Safety of HemoStyp as an Adjunct for Management of Secondary Hemostasis in the Operative Setting for peer review.

Mr. King most recently served as President of Medtronic’s Spinal business, leading the multi-billion dollar division within Medtronic’s Restorative Therapies Group.

The conference call will be concurrently webcast.

TRC Capital’s unsolicited “mini-tender” offer price of $192.00 per share is approximately 4.38% below the $200.80 per share closing price of Amgen’s common stock on Oct. 11, 2019, the last trading day prior to the commencement of the offer

Vanda Pharmaceuticals Inc. announced results of a comparative genomics study presented at the 2019 American Society of Human Genetics conference on October 19, 2019, entitled “Using Patterns in Regions of Homozygosity to Evaluate the Use of Dogs as Preclinical Models in Human Drug Development”..

Sales of $29.1mm, +20% (+13% organic) vs. Q3 2018